Table 1.
Distribution of study subject characteristics by disease grade
| CIN1 | CIN2 | CIN3 | Cancer | |||||
|---|---|---|---|---|---|---|---|---|
| (N=27) | (N=8) | (N=10) | (N=23) | |||||
| Age (range)* | 37.5 | (24–56) | 35 | (21–52) | 37 | (29–50) | 54.3 | (24–75) |
| Race | ||||||||
| African-American | 11 | 41% | 6 | 75% | 4 | 40.0% | 12 | 52% |
| Caucasian | 10 | 37% | 2 | 25% | 6 | 60.0% | 9 | 39% |
| Asian/Other | 0 | 0% | 0 | 0% | 0 | 0.0% | 1 | 4% |
| Unknown | 6 | 22% | 0 | 0% | 0 | 0.0% | 1 | 4% |
| Ethnicity | ||||||||
| Hispanic | 15 | 56% | 5 | 62.5% | 6 | 60.0% | 5 | 22% |
| Non-Hispanic | 12 | 44% | 3 | 37.5% | 4 | 40.0% | 18 | 78% |
| HIV serostatus | ||||||||
| HIV negative | 20 | 74% | 3 | 37.5% | 9 | 90.0% | 22 | 96% |
| HIV positive | 7 | 26% | 5 | 62.5% | 1 | 10.0% | 1 | 4% |
| HPV DNA status | ||||||||
| HPV negative | 5 | 19% | 1 | 12.5% | 2 | 20.0% | 0 | 0% |
| HPV DNA positive | 22 | 81% | 7 | 87.5% | 8 | 80.0% | 23 | 100% |
| High-risk HPV positive† | 15 | 56% | 5 | 62.5% | 8 | 80.0% | 23 | 100% |
*
Mean age (range).
†
High-risk HPV included types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 & 59.